We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A 3D model of a human brain.

Hidden Brain Region May Unlock New Epilepsy Treatment

Cell therapy.

Cell Therapy Treatment Effectively Treats Immune-Compromised Children

A selection of diabetes monitoring and treatment neccessities.

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

Immunotherapy After Kidney Cancer Surgery Improves Overall Survival

Cannabinols Show Neuroprotective Properties in Fruit Flies

News

NCCN, Abraxis BioScience and AstraZeneca Announce Collaboration to Conduct Anti-Cancer Drug Studies

ABRAXANE® in several cancer types to be evaluated along with correlation of response rates and expression of SPARC.

FoldRx Announces Progress with Development Program for Lead Candidate

Company has announced four ongoing studies evaluating Fx-1006A across multiple indications and genetic variations.

Calando Patent Issued for Active Ingredient of Lead siRNA Drug Candidate, CALAA-01

According to Calando, its CALAA-01 is the first and only anti-cancer siRNA drug candidate currently undergoing human clinical trials.

NIH Scientists Identify Link between Brain Systems Implicated in Schizophrenia

The finding suggests that schizophrenia could result from a malfunction anywhere in the link between the three distinct brain circuits.

HairDX Announces Clinical Trial of Genetically Tailored Therapy for Female Baldness

The company has received institutional review board approval to begin a clinical trial of a genetically tailored therapy for female baldness.

Nobel Prize to HPV Researcher Highlights Importance of Cervical Cancer Screening and Prevention

The Nobel Prize-winning discovery of the causal link between human papillomavirus (HPV) and cervical cancer has spurred lifesaving prevention technologies – such as HPV testing and HPV vaccines - that are helping to eradicate cervical cancer globally.

New Reference Materials Sourced to Meet the Needs of the World's Leading Toxicologists

Testing for ‘designer drugs’, ‘legal highs’ and other novel materials is a continuing challenge for clinical, forensic, sports testing and toxicology laboratories.

InnoMed PredTox Consortium Presents Final Results from Non-clinical Safety Studies

The consortium, established to improve drug safety, will meet in Basel to present conclusions from a 36-month non-clinical safety study.

IPSOGEN Expands its U.S. Presence through Licensing Agreement with Quest Diagnostics

Ipsogen entered a non-exclusive license agreement with Quest for the use of the JAK2 V617F mutation in Quest Diagnostic's laboratory developed tests.

OctoPlus Announces Exclusive License and Manufacturing Agreement for Locteron with Biolex

This agreement will immediately transform OctoPlus into a cashflow positive company.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter